These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19927970)

  • 1. Antiemetic drugs.
    Cranwell-Bruce L
    Medsurg Nurs; 2009; 18(5):309-13; quiz 314. PubMed ID: 19927970
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
    de Wit R; Aapro M; Blower PR
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
    Trigg ME; Higa GM
    J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced nausea and vomiting.
    Hesketh PJ
    N Engl J Med; 2008 Jun; 358(23):2482-94. PubMed ID: 18525044
    [No Abstract]   [Full Text] [Related]  

  • 5. NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.
    National Comprehensive Cancer Network (NCCN)
    J Support Oncol; 2004; 2(4):366. PubMed ID: 15357520
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical selection of antiemetics.
    Flake ZA; Scalley RD; Bailey AG
    Am Fam Physician; 2004 Mar; 69(5):1169-74. PubMed ID: 15023018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
    Durand JP; Madelaine I; Scotté F
    Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics.
    Morrow GR; Roscoe JA; Kirshner JJ; Hynes HE; Rosenbluth RJ
    Support Care Cancer; 1998 May; 6(3):244-7. PubMed ID: 9629877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of 5-HT3 receptor antagonists: clinical overview and nursing implications.
    Bremerkamp M
    Clin J Oncol Nurs; 2000; 4(5):201-7. PubMed ID: 11111451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
    Hartvig P
    J Oncol Pharm Pract; 2007 Mar; 13(1):57-8. PubMed ID: 17621570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nausea and vomiting in oncologic therapy. Guidelines for use of setrone].
    Nemec K
    Pharm Unserer Zeit; 2007; 36(5):362-7. PubMed ID: 17722163
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
    Mahesh R; Perumal RV; Pandi PV
    Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
    Gralla R
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-emetic therapy in cancer chemotherapy: current status.
    Herrstedt J; Dombernowsky P
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of nausea nad vomiting in palliative medicine].
    Bausewein C
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):569-73. PubMed ID: 11048341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced nausea and vomiting.
    Lohr L
    Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of nausea, vomiting and anorexia due to anticancer agents].
    Shimada K; Taguchi S
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):760-4. PubMed ID: 12852341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.